ROBERT BRITTON to Anti-Bacterial Agents
This is a "connection" page, showing publications ROBERT BRITTON has written about Anti-Bacterial Agents.
Connection Strength
0.682
-
Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol. 2012 Jul; 20(7):313-9.
Score: 0.177
-
Post-antibiotic gut dysbiosis-induced trabecular bone loss is dependent on lymphocytes. Bone. 2020 05; 134:115269.
Score: 0.076
-
Probiotic Lactobacillus reuteri Prevents Postantibiotic Bone Loss by Reducing Intestinal Dysbiosis and Preventing Barrier Disruption. J Bone Miner Res. 2019 04; 34(4):681-698.
Score: 0.070
-
The role of trehalose in the global spread of epidemic Clostridium difficile. Gut Microbes. 2019; 10(2):204-209.
Score: 0.068
-
Next-Generation Probiotics Targeting Clostridium difficile through Precursor-Directed Antimicrobial Biosynthesis. Infect Immun. 2017 10; 85(10).
Score: 0.064
-
MiniBioReactor Arrays (MBRAs) as a Tool for Studying C. difficile Physiology in the Presence of a Complex Community. Methods Mol Biol. 2016; 1476:235-58.
Score: 0.057
-
Humanized microbiota mice as a model of recurrent Clostridium difficile disease. Microbiome. 2015 Aug 20; 3:35.
Score: 0.056
-
Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology. 2014 May; 146(6):1547-53.
Score: 0.050
-
High efficiency recombineering in lactic acid bacteria. Nucleic Acids Res. 2012 May; 40(10):e76.
Score: 0.043
-
Reuterin disrupts Clostridioides difficile metabolism and pathogenicity through reactive oxygen species generation. Gut Microbes. 2020 11 09; 12(1):1788898.
Score: 0.020